Gardasil 9 has a strong safety record backed by clinical trials involving more than 13,000 participants, post-market surveillance of tens of millions of doses, and reviews by global health authorities. The World Health Organization’s Global Advisory Committee on Vaccine Safety considers HPV vaccines “extremely safe,” and no new adverse events of concern have emerged since the vaccine was licensed.
That said, “safe” doesn’t mean “zero side effects.” Here’s what the data actually show about what to expect, what’s rare, and what the evidence says about the serious concerns you may have seen online.
Common Side Effects
The most frequent reaction to Gardasil 9 is soreness at the injection site. In pre-licensure clinical trials of over 13,000 participants, injection site pain was reported by 72% to 90% of recipients. Swelling occurred in 24% to 40%, and redness in 24% to 34%. These reactions are a normal immune response and typically resolve within a few days.
Beyond the injection site, headache was the most common systemic side effect, reported by roughly 13% to 15% of participants. Fever, nausea, and dizziness also occurred at lower rates. None of these are unusual for vaccines in general, and they tend to be mild and short-lived.
Fainting After the Shot
Fainting (syncope) is a real, well-documented reaction, particularly in adolescents. It’s not unique to Gardasil 9; it happens with other vaccines and even blood draws in this age group. The concern isn’t the fainting itself but the risk of falling and hitting your head. That’s why providers are advised to have you sit or lie down and wait 15 minutes after the injection before leaving. If you feel dizzy, weak, or sweaty in that window, let the person who vaccinated you know right away.
Serious Adverse Events
In clinical trials for the original Gardasil vaccine, serious adverse reactions were reported by 0.8% of vaccine recipients and 1.0% of those who received a placebo. That’s a slightly lower rate in the vaccinated group. Of the entire study population of over 29,000 people, only 0.04% of serious events were judged by investigators to be vaccine-related.
Post-market data tell a similar story. Between December 2014 and June 2017, the FDA reviewed 7,244 reports submitted to the Vaccine Adverse Event Reporting System (VAERS) following HPV vaccination. About 97% were classified as non-serious, meaning they involved expected side effects like injection site pain or headache. Around 3% were classified as serious, a category that includes any event resulting in hospitalization, disability, or death, regardless of whether the vaccine caused it.
During that same period, five deaths were reported among Gardasil 9 recipients in the U.S. The FDA reviewed each case and found no information suggesting a causal relationship between the deaths and the vaccine. Over the broader history of HPV vaccination, more than 80 million doses of the original Gardasil were distributed in the U.S. through 2017, and the overall pattern of VAERS reports revealed no unusual clusters or trends.
Autoimmune Conditions and POTS
One of the most persistent concerns about Gardasil 9 involves conditions like POTS (postural orthostatic tachycardia syndrome) and CRPS (complex regional pain syndrome), both of which involve pain, fatigue, and dysfunction of the autonomic nervous system. These concerns have circulated widely online, driven in part by individual stories that are genuinely distressing.
Large population studies have looked specifically at this question. The American Autonomic Society, which specializes in exactly these types of disorders, reviewed the data and concluded that the evidence does not support a causal link between HPV vaccination and POTS, CRPS, or other forms of autonomic dysfunction. Over 270 million people worldwide had received the HPV vaccine at the time of that review, and no identifiable pattern of autonomic adverse events emerged. The WHO’s safety committee reached the same conclusion: no evidence of a causal association between HPV vaccines and these conditions.
What’s in the Vaccine
Gardasil 9 contains no live virus. It uses virus-like particles, essentially protein shells that look like HPV to your immune system but can’t cause infection. Each dose contains about 225 micrograms of aluminum, used as an adjuvant to strengthen the immune response. That amount is comparable to what’s found in other routine vaccines and is far less than the aluminum most people consume through food and water on a daily basis.
The vaccine is produced using yeast, so people with a known severe allergy to yeast should not receive it. Severe allergic reactions (anaphylaxis) have been reported after vaccination but are rare and can happen with virtually any injectable medication. This is one reason providers keep you under observation after the shot.
Safety During Pregnancy
Gardasil 9 is not recommended during pregnancy, simply because there hasn’t been enough targeted research to confirm it’s beneficial to vaccinate at that time. However, the WHO’s safety committee has reviewed cases of people who were inadvertently vaccinated while pregnant and found no known adverse outcomes in either the mother or infant. If you discover you were pregnant when you received a dose, there’s no indication that it caused harm, but the remaining doses are typically postponed until after delivery.
How Long the Safety Data Span
HPV vaccines have been in use since 2006, giving researchers nearly two decades of real-world safety data. Follow-up studies tracking vaccinated individuals for 10 to 14 years have shown that protection remains effective without waning, and no new safety signals have appeared over that extended monitoring period. The CDC, FDA, WHO, and multiple national health agencies continue active surveillance. The consistent finding across all of these systems is that the safety profile established in clinical trials has held up at a population scale of hundreds of millions of doses.